LMR Partners’s Contineum Therapeutics CTNM Stock Holding History
Bought
Maintained
Sold
Other funds holding CTNM
LMR Partners's CTNM Position: Q3 2026 in Review
LMR Partners opened a new position in Contineum Therapeutics (CTNM) in Q3 2026: 15,600 shares worth $209K. The stake represents ﹤0.01% of the portfolio and ranks #1386 among its holdings.
118 funds tracked by Wall St. Rank hold CTNM as of Q3 2026.
- LMR Partners held 15,600 shares of Contineum Therapeutics worth $209K as of Q3 2026.
- Contineum Therapeutics was a new LMR Partners position in Q3 2026.
- Contineum Therapeutics made up ﹤0.01% of LMR Partners's portfolio in Q3 2026, its #1386 holding.
- 118 funds tracked by Wall St. Rank held Contineum Therapeutics as of Q3 2026.
Based on LMR Partners's 13F filing for Q3 2026, filed 16 Nov 2026.